Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
DKK1 overexpression
i
Other names:
DKK1, Dickkopf WNT Signaling Pathway Inhibitor 1, Dickkopf-Related Protein 1, SK, Dickkopf (Xenopus Laevis) Homolog 1, Dickkopf 1 Homolog (Xenopus Laevis), Dickkopf-Like Protein 1, Dickkopf 1 Homolog, Dickkopf-1 Like, Dickkopf-1, HDkk-1, DKK-1, Dkk-1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
22943
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
DKK1 overexpression
Gastroesophageal Junction Adenocarcinoma
DKK1 overexpression
Gastroesophageal Junction Adenocarcinoma
DKN-01
Sensitive: B - Late Trials
DKN-01
Sensitive
:
B
DKN-01
Sensitive: B - Late Trials
DKN-01
Sensitive
:
B
DKK1 overexpression
Gastric Cancer
DKK1 overexpression
Gastric Cancer
DKN-01
Sensitive: B - Late Trials
DKN-01
Sensitive
:
B
DKN-01
Sensitive: B - Late Trials
DKN-01
Sensitive
:
B
DKK1 overexpression
Gastroesophageal Junction Adenocarcinoma
DKK1 overexpression
Gastroesophageal Junction Adenocarcinoma
pembrolizumab + DKN-01
Sensitive: C3 – Early Trials
pembrolizumab + DKN-01
Sensitive
:
C3
pembrolizumab + DKN-01
Sensitive: C3 – Early Trials
pembrolizumab + DKN-01
Sensitive
:
C3
DKK1 overexpression
Esophageal Squamous Cell Carcinoma
DKK1 overexpression
Esophageal Squamous Cell Carcinoma
pembrolizumab + DKN-01
Sensitive: C3 – Early Trials
pembrolizumab + DKN-01
Sensitive
:
C3
pembrolizumab + DKN-01
Sensitive: C3 – Early Trials
pembrolizumab + DKN-01
Sensitive
:
C3
DKK1 overexpression
Esophageal Adenocarcinoma
DKK1 overexpression
Esophageal Adenocarcinoma
pembrolizumab + DKN-01
Sensitive: C3 – Early Trials
pembrolizumab + DKN-01
Sensitive
:
C3
pembrolizumab + DKN-01
Sensitive: C3 – Early Trials
pembrolizumab + DKN-01
Sensitive
:
C3
DKK1 overexpression
Gastric Cancer
DKK1 overexpression
Gastric Cancer
pembrolizumab + DKN-01
Sensitive: C3 – Early Trials
pembrolizumab + DKN-01
Sensitive
:
C3
pembrolizumab + DKN-01
Sensitive: C3 – Early Trials
pembrolizumab + DKN-01
Sensitive
:
C3
DKK1 overexpression
Endometrial Cancer
DKK1 overexpression
Endometrial Cancer
DKN-01
Sensitive: C3 – Early Trials
DKN-01
Sensitive
:
C3
DKN-01
Sensitive: C3 – Early Trials
DKN-01
Sensitive
:
C3
DKK1 overexpression
Esophageal Squamous Cell Carcinoma
DKK1 overexpression
Esophageal Squamous Cell Carcinoma
DKN-01
Sensitive: C3 – Early Trials
DKN-01
Sensitive
:
C3
DKN-01
Sensitive: C3 – Early Trials
DKN-01
Sensitive
:
C3
DKK1 overexpression
Esophageal Adenocarcinoma
DKK1 overexpression
Esophageal Adenocarcinoma
DKN-01
Sensitive: C3 – Early Trials
DKN-01
Sensitive
:
C3
DKN-01
Sensitive: C3 – Early Trials
DKN-01
Sensitive
:
C3
DKK1 overexpression
Colorectal Cancer
DKK1 overexpression
Colorectal Cancer
5-fluorouracil
Resistant: C3 – Early Trials
5-fluorouracil
Resistant
:
C3
5-fluorouracil
Resistant: C3 – Early Trials
5-fluorouracil
Resistant
:
C3
DKK1 overexpression
Gastroesophageal Junction Adenocarcinoma
DKK1 overexpression
Gastroesophageal Junction Adenocarcinoma
tislelizumab-jsgr + DKN-01
Sensitive: C3 – Early Trials
tislelizumab-jsgr + DKN-01
Sensitive
:
C3
tislelizumab-jsgr + DKN-01
Sensitive: C3 – Early Trials
tislelizumab-jsgr + DKN-01
Sensitive
:
C3
DKK1 overexpression
Ovarian Cancer
DKK1 overexpression
Ovarian Cancer
DKN-01
Sensitive: C3 – Early Trials
DKN-01
Sensitive
:
C3
DKN-01
Sensitive: C3 – Early Trials
DKN-01
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login